Joint Research Organization Applies for Clinical Trial of Microneedle Patch for Obesity Treatment
Medical Companies Apply for Clinical Trial of Microneedle Patch for Obesity Treatment In an effort to mitigate pain, secondary infections, and medical waste associated with current obesity treatment injections, Raphas and Daewon Pharmaceutical have jointly applied for a phase 1 clinical trial of a microneedle patch called ‘DW-1022’. This patch is being developed as an […]
Daewon Pharmaceutical and Raphas Complete Phase 1 Clinical Trial Application for Microneedle Patch Obesity Treatment ‘DW-1022’
Daewon Pharmaceutical and Raphas Complete Phase 1 Clinical Trial Application for Microneedle Patch Obesity Treatment Daewon Pharmaceutical, led by CEO Baek Seung-yeol, and Raphas, led by CEO Jeong Do-hyun, announced on the 8th that they have successfully completed the phase 1 clinical trial application (IND) for their innovative microneedle patch obesity treatment, known as ‘DW-1022’ […]
